 MARINA DEL REY, Calif., Feb. 17, 2022 PRNewswire -- Armata Pharmaceuticals, Inc. NYSE American: ARMP Armata or the Company, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will participate in two upcoming investor conferences. 